Obstructive sleep apnea in chronic obstructive pulmonary disease patients

Area of Science:

• Pulmonary Medicine
• Cardiology
• Sleep Medicine

Background:

• Chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) are prevalent respiratory and cardiovascular disorders.
• Cardiovascular diseases are common comorbidities in both COPD and OSA.
• The overlap syndrome, co-existence of COPD and OSA, affects 1% of adults and results in more severe nocturnal hypoxemia and hypercapnia.

Purpose of the Study:

• To review recent data on the pathophysiological and clinical significance of the COPD-OSA overlap syndrome.
• To explore the interactions between COPD and OSA and their impact on cardiovascular health.

Main Methods:

• Review of recent literature on the overlap syndrome.
• Analysis of pathophysiological mechanisms linking COPD, OSA, and cardiovascular disease.
• Discussion of clinical significance and treatment implications.

Main Results:

• Obstructive ventilatory impairment severity correlates with sleep-related breathing disturbances.
• Early continuous positive airway pressure (CPAP) treatment improves survival, reduces hospitalizations, pulmonary hypertension, and hypoxemia.
• Systemic inflammation and oxidative stress in COPD and OSA may contribute to cardiovascular disease development.

Conclusions:

• Further research at clinical, physiological, and molecular levels is needed to understand overlap syndrome mechanisms and consequences.
• Identifying relationships between overlap syndrome and cardiovascular disease is crucial.
• Ongoing long-term outcome studies will provide further evidence on the clinical significance of the overlap syndrome.